Scientists discovered a way to block hepatitis B infection using an anticancer drug, offering hope for new treatments. Researchers from Memorial Sloan Kettering Cancer Center (MSK), Weill Cornell Medicine, and The Rockefeller University have uncovered a key vulnerability in the hepatitis B virus (HBV), shedding light on how it establishes infection in liver cells. Their [...]from SciTechDaily https://ift.tt/sYA2NeE
